[Mid- and long-term results of thoracic endovascular aortic repair for thoracic aortic pathologies]

Thoracic endovascular aortic repair (TEVAR) for thoracic aortic pathologies has become common worldwide as a less-invasive alternative to open surgery, and satisfactory early outcomes were achieved. However, there have been few reports of mid- and long-term results in this field. In this study, we reviewed the mid- and long-term results of the TEVAR procedure for the treatment of thoracic aortic pathologies. In coming years, there will be intense competition to develop the devices themselves (e.g., branched devices), improve delivery systems, and supplement devices with auxiliary functions. There are high expectations for those next-generation devices and how they will improve and advance treatment methods. Cardiovascular surgeons look forward to the future of hybrid surgery 5 years from now.